XML 25 R12.htm IDEA: XBRL DOCUMENT
v3.20.1

Impairment, Restructuring and Other Charges | 9 Months Ended
--- | ---
Mar. 31, 2020
Impairment, Restructuring and Other Charges |
Impairment, Restructuring and Other Charges | 5. Impairment, Restructuring and Other Charges ​ We endeavor to align our global capacity and infrastructure with demand by our customers as well as fully integrate acquisitions and thereby improve operational efficiency. ​ During the three and nine months ended March 31, 2020, we abandoned a non-core product line in our Healthcare division which resulted in the write-off of assets, including intangible and fixed assets, totaling $3.3 million as we determined that these assets had no value and were permanently impaired. In addition, we continued to recover certain legal costs related to class action litigation and government investigations through insurance reimbursement. We also incurred additional legal fees related to these matters as well as restructuring charges by the divisions as noted in the tables below. This resulted in a net expense of $4.5 million and $1.5 million during the three and nine months ended March 31, 2020, respectively. ​ During the three and nine months ended March 31, 2019, we recovered certain legal costs related to class action litigation and government investigations through insurance reimbursements. We also incurred additional legal fees related to these matters as well as restructuring charges by the divisions as noted in the tables below. This resulted in a net (benefit) expense of $(1.8) million and $1.2 million for the three and nine months ended March 31, 2019, respectively. ​ The following tables summarize impairment, restructuring and other charges (benefit), net for the periods set forth below (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended March 31, 2019
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Optoelectronics and | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | Healthcare | ​ | Manufacturing | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Security Division |  | Division |  | Division |  | Corporate |  | Total
Legal costs (recoveries), net | ​ | $ | — | ​ | $ | — | ​ | $ | — | ​ | $ | (1,777) | ​ | $ | (1,777)
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended March 31, 2020
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Optoelectronics and | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Healthcare | ​ | Manufacturing | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Security Division |  | Division |  | Division |  | Corporate |  | Total
Impairment charges | ​ | $ | — | ​ | $ | 3,258 | ​ | $ | — | ​ | $ | — | ​ | $ | 3,258
Acquisition-related costs | ​ | ​ | 107 | ​ | ​ | — | ​ | ​ | 41 | ​ | ​ | 155 | ​ | ​ | 303
Employee termination costs | ​ | ​ | 328 | ​ | ​ | 466 | ​ | ​ | 259 | ​ | ​ | 50 | ​ | ​ | 1,103
Facility closures/consolidation | ​ | ​ | 30 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 30
Legal costs (recoveries), net | ​ |  | — | ​ |  | — | ​ |  | — | ​ |  | (146) | ​ |  | (146)
Total expensed | ​ | $ | 465 | ​ | $ | 3,724 | ​ | $ | 300 | ​ | $ | 59 | ​ | $ | 4,548
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Nine Months Ended March 31, 2019
​ |  | ​ | ​ |  | ​ | ​ |  | Optoelectronics and |  | ​ | ​ |  | ​ | ​
​ | ​ | ​ | ​ | ​ | Healthcare | ​ | Manufacturing | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Security Division | ​ | Division | ​ | Division | ​ | Corporate | ​ | Total
Acquisition-related costs | ​ | $ | — | ​ | $ | — | ​ | $ | 287 | ​ | $ | — | ​ | $ | 287
Employee termination costs | ​ |  | — | ​ |  | 1,442 | ​ |  | 133 | ​ |  | — | ​ |  | 1,575
Facility closures/consolidation | ​ |  | — | ​ |  | 2,084 | ​ |  | — | ​ |  | — | ​ |  | 2,084
Legal costs (recoveries), net | ​ |  | — | ​ |  | — | ​ |  | — | ​ |  | (2,792) | ​ |  | (2,792)
Total expensed | ​ | $ | — | ​ | $ | 3,526 | ​ | $ | 420 | ​ | $ | (2,792) | ​ | $ | 1,154
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Nine Months Ended March 31, 2020
​ |  | ​ | ​ |  | ​ | ​ |  | Optoelectronics and |  | ​ | ​ |  | ​ | ​
​ | ​ | ​ | ​ | ​ | Healthcare | ​ | Manufacturing | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Security Division | ​ | Division | ​ | Division | ​ | Corporate | ​ | Total
Impairment charges | ​ | $ | — | ​ | $ | 3,258 | ​ | $ | — | ​ | $ | — | ​ | $ | 3,258
Acquisition-related costs | ​ | ​ | 107 | ​ | ​ | — | ​ | ​ | 41 | ​ | ​ | 155 | ​ | ​ | 303
Employee termination costs | ​ |  | 734 | ​ |  | 466 | ​ |  | 277 | ​ |  | 119 | ​ |  | 1,596
Facility closures/consolidation | ​ |  | 30 | ​ |  | — | ​ |  | — | ​ |  | — | ​ |  | 30
Legal costs (recoveries), net | ​ |  | — | ​ |  | — | ​ |  | — | ​ |  | (3,667) | ​ |  | (3,667)
Total expensed | ​ | $ | 871 | ​ | $ | 3,724 | ​ | $ | 318 | ​ | $ | (3,393) | ​ | $ | 1,520
​ The changes in the accrued liability for restructuring and other charges for the nine-month period ended March 31, 2020 were as follows (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Facility | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | Employee | ​ | Closure/ | ​ | ​ | ​ | ​ | ​
​ | ​ | Acquisition- | ​ | Termination | ​ | Consolidation | ​ | Legal Costs and | ​ | ​ | ​
​ |  | related Costs |  | Costs |  | Cost |  | Settlements |  | Total
Balance as of June 30, 2019 | ​ | $ | — | ​ | $ | 432 | ​ | $ | — | ​ | $ | 6,331 | ​ | $ | 6,763
Restructuring and other charges (benefit), net | ​ | ​ | 303 | ​ |  | 1,596 | ​ | ​ | 30 | ​ | ​ | (3,667) | ​ |  | (1,738)
(Payments), adjustments and reimbursements, net | ​ | ​ | (303) | ​ | ​ | (2,022) | ​ | ​ | (30) | ​ | ​ | 1,204 | ​ |  | (1,151)
Balance as of March 31, 2020 | ​ | $ | — | ​ | $ | 6 | ​ | $ | — | ​ | $ | 3,868 | ​ | $ | 3,874
​

X
- Definition The entire disclosure for impairment, restructuring and related activities. Description of impairment costs and restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled. + References No definition available. + Details
Name: | osis_ImpairmentRestructuringAndRelatedActivitiesDisclosureTextBlock
Namespace Prefix: | osis_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RestructuringCostsAndAssetImpairmentChargesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration